Aardvark Therapeutics, Inc. Common Stock AARD Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$69.87M-21.3% | -$57.59M-18.1% | -$48.77M-33.1% | -$36.64M-32.2% | -$27.72M-34.6% | ||
| $42K+16.7% | $36K+5.9% | $34K+6.3% | $32K+68.4% | $19K+18.8% | ||
| $5.72M+44.9% | $3.95M+55.4% | $2.54M+114% | $1.19M+95.9% | $605K+37.8% | ||
| -$61.65M-13.8% | -$54.17M-20.1% | -$45.09M-37.0% | -$32.91M-20.6% | -$27.29M-50.9% | ||
| —— | $95K-5.9% | $101K-1.0% | $102K-1.9% | $104K-4.6% | ||
| —— | —— | —— | —— | -$124.62M-939% | ||
| $449K-99.5% | $89.32M+0.3% | $89.05M+0.1% | $88.94M-48.3% | $171.88M+107% | ||
| —— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Aardvark Therapeutics, Inc. Common Stock generate?
- Aardvark Therapeutics, Inc. Common Stock (AARD) generated -$61.7M in operating cash flow over the trailing twelve months.
- Where does Aardvark Therapeutics, Inc. Common Stock's cash flow data come from?
- Every line is extracted from Aardvark Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.